Xenetic Biosciences – Framingham SOURCE

Xenetic Biosciences Announces $12.5 Million Private Stock Sale

July 26, 2021July 26, 2021 editor biopharmaceutical company, Framingham Company, stock sale, Xenetic Biosciences

Share, email, print, bookmark SOURCE reports.

In full transparency, the following is a press release *** FRAMINGHAM – Xenetic Biosciences, a Framingham-based biopharmaceutical company focused on

Read more

Business Health

Framingham Company Receives Approval To Start Exploratory Biopsy Study in Europe

March 29, 2021March 29, 2021 editor Europe, Framingham Company, study, Xenetic Biosciences

Share, email, print, bookmark SOURCE reports.

In full transparency, the following is a press release submitted to SOURCE through its business wire service. *** FRAMINGHAM –

Read more